易富珍 唐惠仙 黄赞松

    [摘要]肝细胞癌是原发性肝癌最常见的类型。肝细胞癌起病隐匿，发现时多数已进展至中晚期，丧失手术根治的机会。介入治疗具有微创、可重复、安全性高、术后并发症少、适应证广等特点，被广泛应用于临床，已成为肝细胞癌重要的治疗手段和中晚期肝细胞癌的首选治疗手段。近年来肝细胞癌介入化学治疗、介入物理治疗以及介入放射治疗取得较大进展，本文对肝细胞癌介入治疗的研究进展进行综述，为肝细胞癌的诊治研究提供参考。

    [关键词]肝细胞癌;介入治疗;放射治疗;化学治疗;物理治疗;分子靶向治疗;联合治疗

    [中图分类号]R737.3? [文献标识码]A? [文章编号]2095-0616(2022)02-0034-05

    Research updates of interventional therapy in hepatocellular carcinoma

    YI Fuzhen1? TANG Huixian1? HUANG Zansong2，3

    1. Graduate School of Youjiang Medical University for Nationalities，Guangxi，Baise 533000，China;2. Department of Gastroenterology，Affiliated Hospital of Youjiang Medical University for Nationalities，Guangxi，Baise 533000，China;3. Guangxi Clinical Medical Research Center of Hepatobiliary Diseases，Guangxi，Baise 533000，China

    [Abstract] Hepatocellular carcinoma is the most frequently occurring types of primary liver cancer. The onset of hepatocellular carcinoma is hidden. Once discovered，most of them are diagnosed with mid-late stage hepatocellular carcinoma，lost the opportunities for radical operation. Interventional therapy has the characteristics of minimally invasive ......